Integrated Omics Reveals Tollip as an Regulator and Therapeutic Target for Hepatic Ischemia‐Reperfusion Injury in Mice

Abstract

Hepatic ischemia-reperfusion (IR) injury is the leading cause of liver dysfunction and failure after liver resection or transplantation and lacks effective therapeutic strategies. Here, we applied a systematic proteomic analysis to identify the prominent contributors to IR-induced liver damage and promising therapeutic targets for this condition. Based on an unbiased proteomic analysis, we found that toll-interacting protein (Tollip) expression was closely correlated with the hepatic IR process. RNA sequencing analysis and phenotypic examination showed a dramatically alleviated hepatic IR injury by Tollip deficiency both in vivo and in hepatocytes. Mechanistically, Tollip interacts with apoptosis signal-regulating kinase 1 (ASK1) and facilitates the recruitment of tumor necrosis factor receptor-associated factor 6 (TRAF6) to ASK1, leading to enhanced ASK1 N-terminal dimerization and the subsequent activation of downstream mitogen-activated protein kinase (MAPK) signaling. Furthermore, the Tollip methionine and phenylalanine motif and TRAF6 ubiquitinating activity are required for Tollip-regulated ASK1-MAPK axis activation. Conclusion: Tollip is a regulator of hepatic IR injury by facilitating ASK1 N-terminal dimerization and the resultant c-Jun N-terminal kinase/p38 signaling activation. Inhibiting Tollip or its interaction with ASK1 might be promising therapeutic strategies for hepatic IR injury.

<p>The Natural Product Fucoidan Inhibits Proliferation and Induces Apoptosis of Human Ovarian Cancer Cells: Focus on the PI3K/Akt Signaling Pathway</p>

“…Although some chemotherapy regimens can effectively improve the median survival of patients, the recurrence rate of OC remains high and multiple rounds of chemotherapy can also increase the pain and economic burden. [3][4][5] Accordingly, the five-year survival rate of OC is only 46%. 6 Therefore, the development of new therapeutic approaches as well as safe, effective, and economical drugs are urgently required.…”

Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression

“…In NAFLD, the liver is continuously invaded by pathogen associated molecular patterns (PAMPs) (e.g., bacterial products, lipopolysaccharides-LPS), damage-associated molecular patterns (DAMPs) and metabolites (e.g., FFAs, mitochondrial DNA, lipotoxic products) which are sensed by pattern recognition receptors (PRRs), such as toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-like receptors (NLRs) with the consequent activation of pro-inflammatory cascades [94][95][96][97]. The most known DAMP released by damaged cells is high mobility group box 1 protein (HMGB1), which activates TLR4 with the consequent myd-88 dependent NF-kB pathway induction [98,99].…”

Blocking the Hepatic Branch of the Vagus Aggravates Hepatic Ischemia-Reperfusion Injury via Inhibiting the Expression of IL-22 in the Liver

“…Hepatic ischemia-reperfusion injury (IRI) is an inevitable process during liver transplantation, hemorrhagic shock, resection, and other liver surgeries [1][2][3][4]. As a serious complication, ischemia-reperfusion-induced tissue injury accounts for about 10% of early graft failure after liver transplantation, and IRI is an important cause of postsurgery hepatic dysfunction [1,3].…”